Splicing modifier created to treat SMA brought on by mutations in chromosome 5q that bring about survival motor neuron (SMN) protein deficiency. Evrysdi is administered everyday at your home in liquid type by mouth or by feeding tube. Risdiplam, an SMN2 splicing modifier, is at the moment the only orally https://jimp539ejn3.like-blogs.com/profile